Goldman Sachs Starts Moonlake Immunotherapeutics (MLTX ) at Neutral, 'Competing Against Large Pharma Companies Is No Easy Task'
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/2/2026
- Wall Street closes sharply lower as AI cash burn fears spark tech selloff
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil jumps 2%, settles at 6-month highs on fears of escalation in Iran
| (NASDAQ: MLTX) | Delayed: 11.78 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $11.78 | 52 Week High | $ | |||
| Open | $11.78 | 52 Week Low | $ | |||
| Day High | $11.78 | P/E | N/A | |||
| Day Low | $11.78 | EPS | $ | |||
| Volume | 2 | |||||
